PEG3 inhibitors belong to a distinct chemical class that has garnered attention due to their unique interactions and effects within biological systems. These inhibitors are compounds designed to modulate the activity of PEG3, a specific gene that plays a crucial role in various cellular processes. PEG3, also known as paternally expressed gene 3, is a maternally imprinted gene that encodes a zinc finger transcription factor. This transcription factor is involved in the regulation of multiple cellular pathways, including cell growth, differentiation, and apoptosis. PEG3 inhibitors are meticulously crafted molecules that exert their influence by disrupting the normal function of the PEG3 gene or its downstream signaling cascades. These compounds are designed to specifically target the molecular components responsible for the activation and expression of the PEG3 gene. By doing so, they can effectively attenuate the gene's transcriptional activity, leading to a cascade of altered cellular responses. This unique mechanism of action makes PEG3 inhibitors valuable tools for investigating the intricate regulatory mechanisms within cells.
Researchers and scientists have been keenly interested in PEG3 inhibitors for their potential to unveil insights into developmental biology, cellular communication, and disease pathogenesis. Through their precise interference with PEG3-related pathways, these inhibitors have provided a means to dissect the intricate network of interactions that this gene participates in. This, in turn, has contributed to a deeper understanding of the underlying molecular mechanisms governing essential cellular processes. In conclusion, PEG3 inhibitors represent a distinctive class of compounds known for their ability to modulate the activity of the PEG3 gene, a key player in various cellular pathways. By targeting the regulatory mechanisms associated with PEG3, these inhibitors offer a powerful approach to unraveling the complexities of cellular processes. Their potential applications in research and discovery are vast, as they facilitate investigations into the broader realm of molecular biology and cellular function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A natural compound found in grapes and red wine, resveratrol has been investigated for its potential to inhibit PEG3 expression and activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Derived from turmeric, curcumin has anti-inflammatory and potential anti-cancer properties. It has been explored as a PEG3 inhibitor in certain studies. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
This compound is primarily used as an anticonvulsant and mood-stabilizing drug. It has also been studied for its epigenetic effects, including potential inhibition of PEG3. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a well-known histone deacetylase (HDAC) inhibitor. HDACs are enzymes involved in gene expression regulation. Inhibition of HDACs, including TSA, can indirectly impact PEG3 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Similar to TSA, vorinostat is an HDAC inhibitor that has been investigated for its potential effects on gene expression, including PEG3. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another HDAC inhibitor, romidepsin, has been used to target epigenetic changes in cancer cells and might indirectly affect PEG3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor that can alter DNA methylation patterns, potentially impacting PEG3 expression and epigenetic regulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 has been studied for its effects on gene expression and epigenetic modifications. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Yet another HDAC inhibitor, panobinostat, has been explored for its potential in regulating gene expression and epigenetic mechanisms. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
This is a specific inhibitor of the lysine methyltransferase EZH2, which is involved in histone methylation and epigenetic regulation. Inhibition of EZH2 could potentially influence PEG3 expression. | ||||||